Clinical Director, Haemato-oncology Diagnostic Service (HODS) Cheshire & Merseyside Cancer Network, Liverpool Clinical Laboratories, United Kingdom
BIOGRAPHY
MAR 30, 2023 5:10 PM CEST
Molecular analysis in the diagnosis and prognosis of haematological malignancies
Presented at:
OncomineWorld 2023: A Virtual NGS Education Meeting
Speakers
-
Lihui Wang, PhD
Lead, Haemato-oncology Diagnostic Service (HODS) Cheshire & Merseyside Cancer Network, Liverpool Clinical Laboratories, United KingdomBIOGRAPHY
Abstract
This talk will highlight key changes to the various guidelines in myeloid and lymphoid testing, commenting on the current and future landscape of biomarkers. The speakers will then share the developments they have made in the laboratory and how they are applying these guidelines in their molecular service delivery.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...